BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30502475)

  • 41. Differentiating Glioblastoma from Primary Central Nervous System Lymphoma: The Value of Shaping and Nonenhancing Peritumoral Hyperintense Gyral Lesion on FLAIR Imaging.
    Wang P; Shi YH; Li JY; Zhang CZ
    World Neurosurg; 2021 May; 149():e696-e704. PubMed ID: 33548537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences between primary central nervous system lymphoma and glioblastoma: topographic analysis using voxel-based morphometry.
    Yamashita K; Hiwatashi A; Togao O; Kikuchi K; Momosaka D; Hata N; Akagi Y; Suzuki SO; Iwaki T; Iihara K; Honda H
    Clin Radiol; 2019 Oct; 74(10):816.e1-816.e8. PubMed ID: 31400805
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Application of MR morphologic, diffusion tensor, and perfusion imaging in the classification of brain tumors using machine learning scheme.
    Shrot S; Salhov M; Dvorski N; Konen E; Averbuch A; Hoffmann C
    Neuroradiology; 2019 Jul; 61(7):757-765. PubMed ID: 30949746
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary central nervous system lymphoma and glioblastoma: differentiation using dynamic susceptibility-contrast perfusion-weighted imaging, diffusion-weighted imaging, and (18)F-fluorodeoxyglucose positron emission tomography.
    Nakajima S; Okada T; Yamamoto A; Kanagaki M; Fushimi Y; Okada T; Arakawa Y; Takagi Y; Miyamoto S; Togashi K
    Clin Imaging; 2015; 39(3):390-5. PubMed ID: 25547624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perfusion Computed Tomography Parameters Are Useful for Differentiating Glioblastoma, Lymphoma, and Metastasis.
    Onishi S; Kajiwara Y; Takayasu T; Kolakshyapati M; Ishifuro M; Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Yamasaki F
    World Neurosurg; 2018 Nov; 119():e890-e897. PubMed ID: 30099179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differentiation between primary central nervous system lymphoma and glioblastoma: a comparative study of parameters derived from dynamic susceptibility contrast-enhanced perfusion-weighted MRI.
    Nakajima S; Okada T; Yamamoto A; Kanagaki M; Fushimi Y; Okada T; Arakawa Y; Takagi Y; Miyamoto S; Togashi K
    Clin Radiol; 2015 Dec; 70(12):1393-9. PubMed ID: 26382744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differentiation of high-grade glioma and primary central nervous system lymphoma: Multiparametric imaging of the enhancing tumor and peritumoral regions based on hybrid
    Zhang S; Wang J; Wang K; Li X; Zhao X; Chen Q; Zhang W; Ai L
    Eur J Radiol; 2022 May; 150():110235. PubMed ID: 35290912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.
    Makino K; Hirai T; Nakamura H; Murakami R; Kitajima M; Shigematsu Y; Nakashima R; Shiraishi S; Uetani H; Iwashita K; Akter M; Yamashita Y; Kuratsu J
    Ann Nucl Med; 2011 Jul; 25(6):432-8. PubMed ID: 21404136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differentiation of solitary brain metastasis from glioblastoma multiforme: a predictive multiparametric approach using combined MR diffusion and perfusion.
    Bauer AH; Erly W; Moser FG; Maya M; Nael K
    Neuroradiology; 2015 Jul; 57(7):697-703. PubMed ID: 25845813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of intra-tumoral vasculature imaging features on susceptibility weighted imaging in differentiating primary central nervous system lymphoma from glioblastoma: a multiparametric comparison with pathological validation.
    Bhattacharjee R; Gupta M; Singh T; Sharma S; Khanna G; Parvaze SP; Patir R; Vaishya S; Ahlawat S; Singh A; Gupta RK
    Neuroradiology; 2022 Sep; 64(9):1801-1818. PubMed ID: 35435463
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differentiating Between Primary Central Nervous System Lymphomas and Glioblastomas: Combined Use of Perfusion-Weighted and Diffusion-Weighted Magnetic Resonance Imaging.
    Makino K; Hirai T; Nakamura H; Kuroda JI; Shinojima N; Uetani H; Kitajima M; Yano S
    World Neurosurg; 2018 Apr; 112():e1-e6. PubMed ID: 29104150
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Multiple Faces of Nervous System Lymphoma. Atypical Magnetic Resonance Imaging Features and Contribution of the Advanced Imaging.
    Jiménez de la Peña MD; Vicente LG; Alonso RC; Cabero SF; Suárez AM; de Vega VM
    Curr Probl Diagn Radiol; 2017; 46(2):136-145. PubMed ID: 27475832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of occult neoplastic infiltration in the corpus callosum and prediction of overall survival in patients with glioblastoma using diffusion tensor imaging.
    Mohan S; Wang S; Coban G; Kural F; Chawla S; O'Rourke DM; Poptani H
    Eur J Radiol; 2019 Mar; 112():106-111. PubMed ID: 30777198
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Improved performance of non-preloaded and high flip-angle dynamic susceptibility contrast perfusion-weighted imaging sequences in the presurgical differentiation of brain lymphoma and glioblastoma.
    Wang F; Zhou X; Chen R; Kang J; Yang X; Lin J; Liu F; Cao D; Xing Z
    Eur Radiol; 2023 Dec; 33(12):8800-8808. PubMed ID: 37439934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differentiation between primary CNS lymphoma and atypical glioblastoma according to major genomic alterations using diffusion and susceptibility-weighted MR imaging.
    Ozturk K; Soylu E; Cayci Z
    Eur J Radiol; 2021 Aug; 141():109784. PubMed ID: 34051685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Balanced transformer: efficient classification of glioblastoma and primary central nervous system lymphoma.
    Wang S; Wu J; Chen M; Huang S; Huang Q
    Phys Med Biol; 2024 Feb; 69(4):. PubMed ID: 38232389
    [No Abstract]   [Full Text] [Related]  

  • 57. Clinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from Glioblastoma.
    Lee B; Park JE; Bjørnerud A; Kim JH; Lee JY; Kim HS
    AJNR Am J Neuroradiol; 2018 Aug; 39(8):1415-1422. PubMed ID: 30026384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differentiating glioblastoma from primary central nervous system lymphoma of atypical manifestation using multiparametric magnetic resonance imaging: A comparative study.
    Feng A; Li L; Huang T; Li S; He N; Huang L; Zeng M; Lyu J
    Heliyon; 2023 Apr; 9(4):e15150. PubMed ID: 37095995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atypical imaging features of primary central nervous system lymphoma that mimics glioblastoma: utility of intravoxel incoherent motion MR imaging.
    Suh CH; Kim HS; Lee SS; Kim N; Yoon HM; Choi CG; Kim SJ
    Radiology; 2014 Aug; 272(2):504-13. PubMed ID: 24697149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impact.
    Blasel S; Vorwerk R; Kiyose M; Mittelbronn M; Brunnberg U; Ackermann H; Voss M; Harter PN; Hattingen E
    J Neurol; 2018 Mar; 265(3):647-658. PubMed ID: 29383512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.